Hematological Malignancies Stocks List

Recent Signals

Date Stock Signal Type
2021-05-14 ADAP Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-14 ADAP Jack-in-the-Box Bearish Bearish Swing Setup
2021-05-14 ALRN NR7 Range Contraction
2021-05-14 ALRN Narrow Range Bar Range Contraction
2021-05-14 IMGN Lower Bollinger Band Walk Weakness
2021-05-14 MRKR 50 DMA Resistance Bearish
2021-05-14 SNDX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-14 SNDX Stochastic Reached Overbought Strength
2021-05-14 TGTX Lower Bollinger Band Walk Weakness

Recent News for Hematological Malignancies Stocks

Date Stock Title
May 14 TCRR Our Take On TCR2 Therapeutics
May 14 PSTX Poseida Therapeutics (PSDX) Presents At Bank of America Merill Lynch Virtual Healthcare Conference
May 13 TGTX TG Therapeutics Announces Data Presentations at Upcoming Medical Meetings
May 13 SNDX Syndax Announces Participation in Cowen 2nd Annual Virtual Oncology Innovation Summit
May 13 TCRR TCR2 Therapeutics EPS misses by $0.05
May 13 TCRR TCR² Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 13 MRKR Marker Therapeutics, Inc. (MRKR) CEO Peter Hoang on Q1 2021 Results - Earnings Call Transcript
May 12 MRKR Marker Therapeutics EPS misses by $0.02
May 12 MRKR Marker Therapeutics Reports First Quarter 2021 Operating and Financial Results
May 12 MRKR Marker Therapeutics, Inc. to Host Earnings Call
May 12 SNDX Syndax Pharma Updates On Interim Phase 1 Data From SNDX-5613 Leukemia Trial
May 12 MRKR Earnings Scheduled For May 12, 2021
May 12 SNDX Syndax Pharmaceuticals, Inc. (SNDX) CEO Dr. Briggs Morrison on Q1 2021 Results - Earnings Call Transcript
May 11 SNDX Syndax Pharmaceuticals, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 11 SNDX Recap: Syndax Pharmaceuticals Q1 Earnings
May 11 PSTX Poseida Therapeutics EPS beats by $0.05
May 11 SNDX Syndax Pharma announces new data for SNDX-5613 in trial for acute leukemias
May 11 ALRN Aileron Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
May 11 SNDX Syndax Pharmaceuticals EPS beats by $0.13, beats on revenue
May 11 PSTX Poseida Therapeutics Reports Program Updates and Financial Results for the First Quarter 2021
Related Industries: Biotechnology